Not Signed In -
Amphetamine and Dextroamphetamine ER |
Adderall XR |
Adderall® CII is a pharmaceutical stimulant amphetamine used to treat attention-deficit hyperactivity disorder and narcolepsy. It was first prescribed in the 1970s as an anorectic (under the brand name Obetrol®), but such usage is now rare. Adderall 25 mg XR Capsules Use 1/4 Dextroamphetamine Saccharate 1/4 Dextroamphetamine Sulfate (Dexedrine®) 1/4 Amphetamine Aspartate 1/4 Amphetamine Sulfate The four component salts are claimed to be metabolised at different rates. The ...
Wikipedia - [full article]
Amphetamine and Dextroamphetamine ER Clinical Trials
- Efficacy and Safety of SPD465 in Adults with Moderately Symptomatic ADHD.
ClinicalTrials.gov Identifier: NCT00152022 - Completed
Attention Deficit Disorder with Hyperactivity.
- Safety and Efficacy of SPD465 in Adults with ADHD
ClinicalTrials.gov Identifier: NCT00202605 - Completed
Attention Deficit Disorder with Hyperactivity
- Safety of SPD465 in Treating Adults with ADHD.
ClinicalTrials.gov Identifier: NCT00152035 - Completed
Attention Deficit Disorder with Hyperactivity.
- Efficacy and Safety of SPD465 in Adults with ADHD
ClinicalTrials.gov Identifier: NCT00150579 - Completed
Attention Deficit Disorder with Hyperactivity
- Dextroamphetamine-Amphetamine Compared With Methylphenidate in Treating Children With Depression and Problems With Memory, Attention, and Thinking Caused By Cancer Treatment
ClinicalTrials.gov Identifier: NCT00069927 - Completed
unspecified childhood solid tumor, protocol specific; Depression; neurotoxicity
- The Effects of Dextroamphetamine on Brain Function
ClinicalTrials.gov Identifier: NCT00004556 - Recruiting
Healthy
- Cognitive Correlates of Substance Abuse - 11
ClinicalTrials.gov Identifier: NCT00000346 - Active, not recruiting
Amphetamine-Related Disorders
- Cognitive Correlates of Substance Abuse, Part 2 - 16
ClinicalTrials.gov Identifier: NCT00000351 - Active, not recruiting
Amphetamine-Related Disorders
- Randomised Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence
ClinicalTrials.gov Identifier: NCT00123370 - Active, not recruiting
Amphetamine Dependence
- To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline. - 1
ClinicalTrials.gov Identifier: NCT00100074 - Active, not recruiting
Amphetamine-Related Disorders
- Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
ClinicalTrials.gov Identifier: NCT00000350 - Active, not recruiting
Amphetamine-Related Disorders; Tobacco Use Disorder
- Assessment of Potential Interactions between Methamphetamine and Bupropion - 1
ClinicalTrials.gov Identifier: NCT00040040 - Active, not recruiting
Amphetamine-Related Disorders
- Assessment of Potential Interactions between Methamphetamine and Selegiline - 1
ClinicalTrials.gov Identifier: NCT00033072 - Active, not recruiting
Amphetamine-Related Disorders
- Bupropion for the Treatment of Methamphetamine Dependence - 1
ClinicalTrials.gov Identifier: NCT00069251 - Active, not recruiting
Amphetamine-Related Disorders
- Ondansetron for the Treatment of Methamphetamine Dependence - 1
ClinicalTrials.gov Identifier: NCT00040053 - Active, not recruiting
Amphetamine-Related Disorders
- Assessment of Interactions between Methamphetamine and Aripiprazole - 1
ClinicalTrials.gov Identifier: NCT00089440 - Active, not recruiting
Amphetamine-Related Disorders
- A Pilot Study of Citicoline Add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
ClinicalTrials.gov Identifier: NCT00377299 - Recruiting
Amphetamine Abuse; Amphetamine Dependence; Bipolar Disorder; Major Depressive Disorder
- Multiphase Efficacy Study of venlafaxine ER to Treat Recurrent Depression
ClinicalTrials.gov Identifier: NCT00046020 - Active, not recruiting
Depression
- Amphetamine Cocaine Interaction Study - 2
ClinicalTrials.gov Identifier: NCT00000305 - Completed
Cocaine-Related Disorders
- Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1
ClinicalTrials.gov Identifier: NCT00265278 - Active, not recruiting
Amphetamine-Related Disorders
- Tranylcypromine, Tranylcypromine Plus Dextroamphetamine and Tranylcypromine Plus Triiodothyronine as Treatment for Refractory Depression.
ClinicalTrials.gov Identifier: NCT00296686 - Active, not recruiting
Major Depression
- A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1
ClinicalTrials.gov Identifier: NCT00267657 - Active, not recruiting
Amphetamine-Related Disorders
- Study of DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
ClinicalTrials.gov Identifier: NCT00087737 - Active, not recruiting
Major Depressive Disorder
- Study Of DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder
ClinicalTrials.gov Identifier: NCT00090649 - Active, not recruiting
Major Depressive Disorder
- Dextro-Amphetamine Versus Caffeine in Treatment-Resistant OCD
ClinicalTrials.gov Identifier: NCT00363298 - Recruiting
Obsessive-Compulsive Disorder
- Long-Term Behavior Change - 1
ClinicalTrials.gov Identifier: NCT00158197 - Recruiting
Adherence; Amphetamine-Related Disorders; Behavior Therapy; Contingency management; Drug Counseling; health behaviors; methamphetamine; ...
- Cetuximab and Carbo for ER/PR/HER2 Negative BC
ClinicalTrials.gov Identifier: NCT00420329 - Active, not recruiting
Breast Cancer
- Dextroamphetamine-Cocaine Behavioral Intervention - 5
ClinicalTrials.gov Identifier: NCT00000308 - Completed
Cocaine-Related Disorders
- Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00329186 - Active, not recruiting
Depressive Disorder, Major
- Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients with Mood Disorders
ClinicalTrials.gov Identifier: NCT00097175 - Recruiting
Depressive Disorder, Major
- Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
ClinicalTrials.gov Identifier: NCT00218348 - Recruiting
Cocaine-Related Disorders
- Preoperative Cisplatin in Early Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00148694 - Active, not recruiting
Breast Cancer; ER Negative Breast Cancer; PR Negative Breast Cancer; HER-2 Negative Breast Cancer
- Risperidone Vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
ClinicalTrials.gov Identifier: NCT00179244 - Active, not recruiting
Unipolar Depression
- A Case Management Intervention to Prevent ER Visits in HIV-Infected Persons
ClinicalTrials.gov Identifier: NCT00187590 - Active, not recruiting
HIV
- A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00396565 - Active, not recruiting
Schizophrenia
- Depakote-ER for Depressive and Bipolar Depression
ClinicalTrials.gov Identifier: NCT00226343 - Active, not recruiting
Bipolar Disorder
- Tyrosine for Methamphetamine Dependence - 1
ClinicalTrials.gov Identifier: NCT00000322 - Completed
Amphetamine-Related Disorders
- Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
ClinicalTrials.gov Identifier: NCT00000306 - Completed
Cocaine-Related Disorders; Opioid-Related Disorders
- Double-Blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
ClinicalTrials.gov Identifier: NCT00194116 - Active, not recruiting
Bipolar Disorder
- Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-Menopausal Patients
ClinicalTrials.gov Identifier: NCT00303524 - Active, not recruiting
Breast Cancer
- Brain Function in Response to Motivational Stimuli
ClinicalTrials.gov Identifier: NCT00047866 - Recruiting
Drug Dependence
- Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00199966 - Active, not recruiting
Bipolar Disorder
- Paliperidone ER Study of Economic, Functional, and Clinical Outcomes.
ClinicalTrials.gov Identifier: NCT00488891 - Recruiting
Schizophrenia
- Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00511953 - Active, not recruiting
Hot Flashes
- Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
ClinicalTrials.gov Identifier: NCT00202514 - Active, not recruiting
Alcoholism; Alcohol Related Disorders; Mood Disorders
- Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
ClinicalTrials.gov Identifier: NCT00000304 - Completed
Cocaine-Related Disorders; Substance-Related Disorders
- Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-Deficit Hyperactivity Disorder (ADHD)
ClinicalTrials.gov Identifier: NCT00514202 - Recruiting
Attention Deficit Disorder With Hyperactivity; Cocaine-Related Disorders; Substance-Related Disorders
- Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00181727 - Active, not recruiting
Bipolar Disorder; Mania
- Brief Intervention to Reduce STDs in ER Drug Users - 1
ClinicalTrials.gov Identifier: NCT00218400 - Recruiting
Substance-Related Disorders; Sexual Risk Behaviors
- A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
ClinicalTrials.gov Identifier: NCT00227123 - Recruiting
Bipolar Disorder; Cocaine Dependence; Amphetamine Dependence
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-Release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00309686 - Active, not recruiting
Affective Psychosis, Bipolar; Bipolar Disorder; Mania
- Naturalistic Study, Comparison of Divalproex ER and Quetiapine for Adults With Acute Mania or Mixed Episodes
ClinicalTrials.gov Identifier: NCT00397020 - Recruiting
Bipolar Disorder
- A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00309699 - Active, not recruiting
Bipolar Disorder; Mood Disorders
- Effects of Sustained Release d-Amphetamine and Buprenorphine on Drug Seeking Behavior in Opioid and Cocaine Dependent Individuals Who Are Not Seeking Treatment
ClinicalTrials.gov Identifier: NCT00429767 - Recruiting
Heroin Dependence; Opioid-Related Disorders; Cocaine Abuse or Dependence
- Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER.
ClinicalTrials.gov Identifier: NCT00211250 - Recruiting
Mood Disorder
- Depakote ER in Bipolar Depression
ClinicalTrials.gov Identifier: NCT00186186 - Active, not recruiting
Depression, Bipolar
- Free Treatment for Cocaine Dependence: A Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence
ClinicalTrials.gov Identifier: NCT00421603 - Recruiting
Cocaine Dependence
- Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
ClinicalTrials.gov Identifier: NCT00535145 - Recruiting
Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
- Panic Disorder Study
ClinicalTrials.gov Identifier: NCT00038896 - Active, not recruiting
Panic Disorder
- Panic Disorder Study
ClinicalTrials.gov Identifier: NCT00044772 - Active, not recruiting
Panic Disorder
- Evaluate the Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children Following Discharge From the ER/Outpatient Care Facility
ClinicalTrials.gov Identifier: NCT00189436 - Recruiting
Asthma
- Tolerability and Efficacy of Depakote-ER in the Elderly
ClinicalTrials.gov Identifier: NCT00318929 - Recruiting
Elderly; Epilepsy; Seizures
- Study of Paliperidone ER in Adolescents and Young Adults With Autism
ClinicalTrials.gov Identifier: NCT00549562 - Recruiting
Autism
- Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
ClinicalTrials.gov Identifier: NCT00525135 - Recruiting
Head and Neck Cancer
- An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00473434 - Recruiting
Schizophrenia
- A Study of the Efficacy and Safety of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00524043 - Recruiting
Schizophrenia
- Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension
ClinicalTrials.gov Identifier: NCT00547300 - Recruiting
Hypertension
- Divalproex Sodium ER in Adult Autism
ClinicalTrials.gov Identifier: NCT00211796 - Recruiting
Autism
- A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00460512 - Recruiting
Schizophrenia
- Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
ClinicalTrials.gov Identifier: NCT00315900 - Recruiting
Agitation; Dementia
- A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients.
ClinicalTrials.gov Identifier: NCT00518323 - Recruiting
Schizophrenia
- A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
ClinicalTrials.gov Identifier: NCT00566631 - Recruiting
Schizophrenia
- Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics
ClinicalTrials.gov Identifier: NCT00505531 - Recruiting
Chronic Pain
- Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
ClinicalTrials.gov Identifier: NCT00204503 - Active, not recruiting
Bipolar I or II Depression and Alcohol Abuse or Dependence
- Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) for the Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) and Cocaine Dependence
ClinicalTrials.gov Identifier: NCT00553319 - Recruiting
Adult Attention Deficit Hyperactivity Disorder; Cocaine Dependence
- Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
ClinicalTrials.gov Identifier: NCT00479401 - Recruiting
Parkinson Disease
- Preoperative Cisplatin and Bevacizumab in ER-, PR-, Her-2 Negative Breast Cancer
ClinicalTrials.gov Identifier: NCT00580333 - Recruiting
Breast Cancer
- Trial Evaluating the Safety and Efficacy of 2 Doses of ER OROS Paliperidone in Acute Adult Schizophrenics
ClinicalTrials.gov Identifier: NCT00077714 - Completed
Schizophrenia
- Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
ClinicalTrials.gov Identifier: NCT00488319 - Recruiting
Dementia Praecox.; Schizophrenia; Psychotic Disorders; Schizophrenic Disorders
- An Open-Label Extension Study With Flexible Dosing of Extended-Release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
ClinicalTrials.gov Identifier: NCT00487435 - Recruiting
Low Back Pain; Pain; Osteoarthritis
- Phase II Letrozole + Herceptin in Her2neu Positive, ER and/or PR Receptor (+),Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00134680 - Active, not recruiting
Metastatic breast cancer
- A 12-Week Study of Pramipexole ER in Patients With Parkinson?s Disease, Followed by a 52-Week Long-Term Treatment Period
ClinicalTrials.gov Identifier: NCT00560508 - Recruiting
Parkinson Disease
- Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00303615 - Recruiting
Metastatic Breast Cancer
- A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
ClinicalTrials.gov Identifier: NCT00449176 - Recruiting
Low Back Pain
- An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
ClinicalTrials.gov Identifier: NCT00465088 - Recruiting
Hyperlipidemia; Mixed Dyslipidemia
- Phase II Trial of Cetuximab Alone and in Combination With Carboplatin in ER-Negative, PR-Negative, HER-2 Nonoverexpressing Metastatic Breast Cancers (LCCC 0403)
ClinicalTrials.gov Identifier: NCT00492375 - Recruiting
Metastatic Breast Cancer
- Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
ClinicalTrials.gov Identifier: NCT00306475 - Recruiting
Schizophrenia; Schizoaffective Disorder
- Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease
ClinicalTrials.gov Identifier: NCT00558025 - Recruiting
Parkinson Disease
- Trial of Letrozole Plus OSI-774 (Tarceva) in Post-Menopausal Women With Estrogen Receptor (ER) and/or Progesterone Receptor (PR)-Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00179296 - Recruiting
Breast Cancer; Neoplasm Metastasis
- A Phase III Trial to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
ClinicalTrials.gov Identifier: NCT00421928 - Recruiting
Pain; Osteoarthritis, Knee
- A Study to Measure the Effect of Tolterodine ER on the Thickness of the Bladder Wall in Patients with Overactive Bladder
ClinicalTrials.gov Identifier: NCT00137397 - Completed
Urinary Incontinence
- Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients.
ClinicalTrials.gov Identifier: NCT00526045 - Recruiting
Breast Cancer; Hematologic Neoplasms
- Long-Term Safety Study of Open-Label Pramipexole ER in Patients With Advanced PD
ClinicalTrials.gov Identifier: NCT00577460 - Not yet recruiting
Parkinson Disease
- PREDICT TRIAL- Neoadjuvant Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women Expressing Hormonal Receptors ( ER and PR)
ClinicalTrials.gov Identifier: NCT00237133 - Recruiting
Locally Advanced Breast Cancer
- Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population
ClinicalTrials.gov Identifier: NCT00207935 - Recruiting
Epilepsy; Mental Retardation; Developmental Disabilities
- Tailored Teen Alcohol and Violence Prevention in the ER
ClinicalTrials.gov Identifier: NCT00251212 - Recruiting
Violence; Alcohol Abuse
- Maintenance Treatment with Capecitabine Vs. Observation in ER, PgR and HER2 Negative Breast Cancer Patients.
ClinicalTrials.gov Identifier: NCT00130533 - Recruiting
Breast cancer.
- Evaluating Extended-Release (ER) OROS Paliperidone Versus Placebo on Sleep in Schizophrenia Subjects
ClinicalTrials.gov Identifier: NCT00105326 - Completed
Schizophrenia; Insomnia
- Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00517361 - Recruiting
Metastatic Breast Cancer
- Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+)Breast Cancer
ClinicalTrials.gov Identifier: NCT00371345 - Recruiting
Breast Cancer; Metastasis
Resources
- Adderall XR (Drug Digest)
- Amphetamine and Dextroamphetamine ER (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
